Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1776 record(s)

Req # A-2023-0021

Data relating to variations in CIHR’s budget dedicated to graduate student scholarships, for the period of 2007-2008 to 2023-2024.

Organization: Canadian Institutes of Health Research

0 page(s)
April 2024

Nothing to report this month

Organization: Toronto Port Authority

April 2024

Req # A-2023-0015

A copy of the following Briefing Notes: 2023-0202 — Briefing note to the President: Meeting with Alliance of Canadian Comprehensive Research Universities (ACCRU); 2023-0203 — Briefing note to the President: Meeting with Universities Canada; 2023-0211 — Briefing note to the President: Meeting with HealthcareCan; 2023-0212 — Briefing note to the President: Meeting with Research Canada; 2023-0214 — Briefing note to the President: Overview of the Finance Modernization Initiative; 2023-0215 — Briefing note to the President: Meeting with the Alliance of Canadian Comprehensive Research Universities (ACCRU); 2023-0219 — Briefing note to the President: Meeting with Dr. Marie-Josée Hébert on the Pan-Canadian Health Data Strategy; 2023-0223 — Briefing note to the President: U.S. Executive Order the Invent it Here, Make it Here Initiative; 2023-0226 — Briefing note to the President: Meeting with U15 Research Committee.

Organization: Canadian Institutes of Health Research

101 page(s)
February 2024

Req # A-2023-0016

Documentation regarding a report on the work environment of Research Programmes.

Organization: Canadian Institutes of Health Research

61 page(s)
February 2024

Req # A-2019-000270

Adverse Drug Reactions (ADRs). Report numbers: 000146129, 000191438, 000335588, 000335771, 000338151, 000345474, 00389283, 000390319, 000593310, E2B_00570261, E2B_00570262, E2B_00570263, E2B_00570264.

Organization: Health Canada

81 page(s)
February 2024

Req # A-2020-000388

Adverse Drug Reactions (ADRs). Report numbers: E2B_02731350, E2B_02777680, E2B_02810755, E2B_02838946, E2B_02852030, E2B_02856401, E2B_02777244, 000735201, E2B_02869967, E2B_02869987, E2B_02869946, E2B_02871897, E2B_02871900, E2B_02871882, E2B_02871883.

Organization: Health Canada

185 page(s)
February 2024

Req # A-2020-000647

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE. Report numbers: 000736259, 000738096, 000911912, E2B_02993730, E2B_03001785, E2B_03004317, E2B_03005410, E2B_03015111, E2B_03020794, E2B_03024205, E2B_03034122, E2B_03038830, E2B_03047792. ADRs for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_03047105, E2B_03003181, E2B_03005697, 000908663. ADR for PANTOPRAZOLE SODIUM. Report number: E2B_03045008. ADR for TECTA. Report number: E2B_03014229.

Organization: Health Canada

563 page(s)
February 2024

Req # A-2020-000731

Adverse Drug Reactions (ADRs) for Estrogel. Report numbers: 000693076, E2B_002778333. ADR for Ezetrol. Report number: E2B_01181304. ADRs for Fosamax. Report numbers: 000675450, 00685185, E2B_00037382, 000518360, 000555402, 000543195, E2B_00256053, E2B_00066044.

Organization: Health Canada

221 page(s)
February 2024

Req # A-2020-000800

Adverse Drug Reactions (ADRs) for Fosamax. Report numbers: E2B_00498826, E2B_00498902, E2B_00500827, E2B_00506460, E2B_00786970, E2B_00894613, E2B_00894617, E2B_00894629, E2B_00896465, E2B_00898784, E2B_00898796, E2B_00898918, E2B_00941125, E2B_00944258, E2B_00946463, E2B_00947254, E2B_00786948, E2B_00792724, E2B_01103249, E2B_01104135.

Organization: Health Canada

1365 page(s)
February 2024

Req # A-2020-000870

Adverse Drug Reactions (ADRs). Report numbers: E2B_01674763, E2B_02137119, 000723810, 000724215, 000724308, 000724654, 000724751, E2B_02429833, E2B_02438547, E2B_02304224, E2B_02304226, E2B_02359312.

Organization: Health Canada

98 page(s)
February 2024
Date modified: